Equity Research Update: Amarin (AMRN) Reaches Positive Cash Flow Ahead of Schedule Following Global Restructuring
Business Overview Amarin Corporation plc (NASDAQ: AMRN) is a global pharmaceutical company dedicated to reducing the cardiovascular disease (CVD) burden for patients and advancing cardiovascular care worldwide. The company owns and supports a global branded product, which is approved by multiple regulatory authorities based on a proven efficacy and safety track record. The company’s commercialization […]



